Guidelines on the insertion and management of central venous access devices in adults

International Journal of Laboratory Hematology

Volumn 29, Issue 4, 2007, Pages 261-278

  Bishop, L ^a   Dougherty, L ^b   Bodenham, A ^c   Mansi, J ^a   Crowe, P ^d   Kibbler, C ^e   Shannon, M ^f   Treleaven, J ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c Leeds Infirmary   (United Kingdom)

^d BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Coagulation; Heparin; PBSC transplantation; Venous access devices

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN; WARFARIN;

ANTIBIOTIC PROPHYLAXIS; APHERESIS; BLEEDING; BLOOD CLOTTING DISORDER; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VEIN; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; ECHOGRAPHY; FLUOROSCOPY; HUMAN; INFECTION; INFORMED CONSENT; LONG TERM CARE; LOW DRUG DOSE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; THROMBOSIS; VASCULAR ACCESS DEVICE;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT FAILURE; HUMANS; THROMBOSIS;

EID: 34447272677     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00931.x     Document Type: Review

References (95)

1. Allon M. (2003) Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clinical and Infectious Diseases 36, 1539 1544.
2. Ansell J., Hirsh J., Poller L., Bussey H., Jacobson A. Hylek E. (2004) The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126, 204 233.
3. Baglin T.P., Keeling D.M. Watson H.G. For the British Committee for Standards in Haematology (2005) BCSH Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. British Journal of Haematology 132, 277 285.
4. Barrera R., Mina B., Huang Y. Groeger J.S. (1996) Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 78, 2025 2030.
5. BCSH (2003) Guidelines for the use of platelet transfusions. British Journal of Haematology 122, 10 23.
6. BCSH (2006) Guidelines on the use and monitoring of heparin. British Journal of Haematology 133, 19 34.
7. BCSH Guidelines (1997) Guidelines on the insertion and management of central venous lines. British Journal of Haematology 98, 1041 1047.
8. Bessoud B., de Baere T., Kuoch V., Desruennes E., Cosset M.F., Lassau N. Roche A. (2003) Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in paediatric and adult patients. American Journal of Radiology 180, 527 532.
9. Betjes M.G. van Agteren M. (2004) Prevention of dialysis-related sepsis with a citrate-taurolidine-containing lock solution. Nephrology Dialysis and Transplantation 19, 1546 1551.
10. Camp-Sorrell D. (1992) Implantable ports: everything you always wanted to know. Journal of Intravenous Nursing 15, 262 273.
11. Carratala J. (2002) The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clinical Microbiological Infections 8, 282 289.
12. Chernecky C., Macklin D., Nugent K. Waller J.L. (2002) The need for shared decision making in the selection of vascular access device: an assessment of patients and clinicians. Journal of Vascular Access Devices 7, 34 39.
13. Cicalini S., Palmieri F. Petrosillo N. (2004) Clinical review: new technologies for prevention of intravascular catheter-related infections. Critical Care 8, 157 162.
14. Conn C. (1993) The importance of syringe size when using an implanted vascular access device. Journal of Vascular Access Nursing 3, 11 18.
15. Cook D., Randolph A., Kernerman P., Cupido C., King D., Soukup C. Brun-Buisson C. (1997) Central venous catheter replacement strategies: A systematic review of the literature. Critical Care Medicine 25, 1417 1424.
16. Cortelezzi A.N., Moia M., Falanga A., Pogliani E.M., Agnelli G., Bonizzoni E., Gussoni G., Barbui T. Mannucci P.M. (2005) CATHEM Study Group. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. British Journal of Haematology 129, 811 817.
17. Couban S., Goodyear M., Burnell M., Dolan S., Wasi P., Barnes D., Macleod D., Burton E., Andreou P. Anderson D.R. (2005) Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. Journal of Clinical Oncology 20, 4063 4069.
18. Crain M.R., Horton M.G. Mewissen M.W. (1998) Fibrin sheaths complicating central venous catheters. American Journal of Radiology 171, 341 346.
19. Crnich C.J. Maki D.G. (2002) The promise of novel technology for the prevention of intravascular device-related blood stream infections II long-term devices. Clinical and Infectious Disease 1, 1232 1242.
20. Deicher S.R., Fesen M.R., Kiproff P.M., Hill P.A., Li X., McCluskey E.R. Semba C.P. (2002) Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. Journal of Clinical Oncology 20, 317 324.
21. Dezfulian C., Lavelle J., Nallamothu B.K., Kaufman S.R. Saint S. (2003) Rates of infection for single lumen versus multilumen central venous catheters: a meta-analysis. Critical Care Medicine 31, 2385 2390.
22. Doerfler M.E., Kaufman B. Goldenberg A.S. (1996) Central venous in patients with disorders of hemostasis.catheter placement. Chest 110, 185 188.
23. Dougherty L. (2004) Vascular Access Devices. In : Manual of Clinical Nursing Procedures (eds L. Dougherty S. Lister 6th edn, pp. 724 773. Blackwell Science, Oxford.
24. Douketis J.D., Johnson J.A. Turpie A.G. (2004) Low molecular weight heparin as bridging anticoagulation during interruption of warfarin. Archives of Internal Medicine 164, 1319 1326.
25. Evans G., Luddington R. Baglin T. (2001) Beriplex P/N reverses severe warfarin-induced over anticoagulation immediately and completely in patients presenting with major bleeding. British Journal of Haematology 115, 998 1001.
26. Farkas J.C., Liu N., Bleriot J.P., Chevret S., Goldstein F.W. Carlet J. (1992) Single versus triple-lumen central catheter-related sepsis: a prospective randomised study in a critically ill population. American Journal of Medicine 93, 277 282.
27. Fernandez-Hidalgo N., Almirante B., Calleja R., Ruiz I., Planes A.M., Rodriguez D., Pigrau C. Pahissa A. (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. The Journal of Antimicrobial Chemotherapy 57, 1172 1180.
28. Fisher N.C. Mutimer D.J. (1999) Central venous cannulation in patients with liver disease and coagulopathy - a prospective audit. Intensive Care Medicine 25, 481 485.
29. Fitzsimmons C., Gilleece M., Ranson M., Wardley A., Morris C. Scarffe J. (1997) Central venous catheter placement: extending the role of the nurse. Journal of the Royal College of Physicians of London 31, 533 535.
30. Fletcher S.J. (2005) Catheter related blood stream infection. Continuing Education in Anaesthesia. Critical Care & Pain 5, 49 451.
31. Fletcher S.J. Bodenham A.R. (2000) Safe placement of central venous catheters: where should the tip of the catheter lie? British Journal of Anaesthesia 85, 188 191.
32. Frey A.M. Schears G.J. (2006) Why are we stuck on tape and suture? A review of catheter securement devices. Journal of Infusional Nursing 29, 34 38.
33. Gabriel J. (1999) Long-term central venous access. In : Intravenous Therapy in Nursing Practice (eds L. Dougherty J. Lamb pp. 301 333. Churchill Livingstone Ltd, Edinburgh.
34. Galloway S. Bodenham A.R. (2004) Long-term central venous access. British Journal of Anaesthesia 92, 722 734.
35. Garland J.S., Alex C.P., Henrickson K.J., McAuliffe T.L. Maki D.G. (2005) A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 116, 198 205.
36. Giacometti A., Cirioni O., Ghiselli R., Orlando F., Mocchegiani F., Silvestri C., Licci A., De Fusco M., Provinciali M., Saba V. Scalise G. (2005) Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrobial Agents in Chemotherapy 49, 4042 4045.
37. Gillies D., O'Riordan E., Carr D., O'Brien I., Frost J. Gunning R. (2003) Central venous catheter dressings: a systematic review. Journal of Advanced Nursing 44, 623 632.
38. Goetz A., Wagener M., Miller J.M. Muder R.R. (1998) Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infection Control and Hospital Epidemiology 19, 842 845.
39. Goodman M. (2000) Chemotherapy: principles of administration. In : Cancer Nursing (ed. C. Henke Yarbro 5th edn, 385 443. Jones and Bartlett, Boston.
40. Goodwin M.L. Carlson I. (1993) The peripherally inserted central catheter: a retrospective look at 3 years insertions. Journal of Intravenous Nursing 16, 92 103.
41. Groeger J.S., Lucas A.B., Thaler H.T., Friedlander-Klar H., Brown A.E., Kiehn T.E. Armstrong D. (1993) Infectious morbidity associated with use of long-term venous access devices in patients with cancer. Annals of Internal Medicine 119, 1168 1174.
42. Hadaway L.C. (1995) Comparison of vascular access devices. Seminars in Oncology Nursing 11, 154 166.
43. Hamilton H. (2000) Selecting the correct intravenous device: nursing assessment. British Journal of Nursing 9, 968 978.
44. Hamilton H. (2004) Advantages of a nurse-led central venous access vascular service. The Journal of Vascular Access 5, 109 112.
45. Hamilton H. Fermo K. (1998) Assessment of patients requiring IV therapy via a central venous route. British Journal of Nursing 7, 451 460.
46. Hatfield A. Bodenham A.R. (1999) Portable ultrasound for difficult venous access. British Journal of Anaesthesia 82, 822 826.
47. Hind D., Calvert N., McWilliams R., Davidson A., Paisley S., Beverley C. Thomas S. (2003) Ultrasonic locating devices for central venous cannulation: a meta-analysis. British Medical Journal 327, 361 368.
48. Joynt G.M., Kew J., Gomersall C.D., Leung V.Y. Liu E.K. (2000) Deep vein thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 117, 178 183.
49. Kim S.H., Song K.I., Chang J.W., Kim S.B., Sung S.A., Jo S.K., Cho W.Y. Kim H.K. (2006) Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney International 69, 161 164.
50. Knutstad K., Hager B. Hauser M. (2003) Radiological diagnosis and management of complications related to central venous access. Acta Radiologica 44, 508 516.
51. Lameris J.S., Post P.J., Zonderland H.M., Gerritsen P.G., Kappers-Klunne M.C. Schutte H.E. (1990) Percutaneous placement of Hickman catheters: comparison of sonographically guided and blind techniques. American Journal of Radiology 155, 1097 1099.
52. Laxson C.J. Titler M.G. (1994) Drawing coagulation studies from arterial lines: an integrative literature review. American Journal of Critical Care 3, 16 22.
53. Ley B.E., Jalil N., McIntosh J., Smart A., Wilson M., Foot A.B. Millar M.R. (1996) Bolus of infusion teicoplanin for intravascular-associated infections in immunocompromised patients? Journal of Antimicrobial Chemotherapy 38, 1091 1095.
54. Logghe C., Van Ossel C., D'Hoore W., Ezzedine H., Wauters G. Haxhe J.J. (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. Journal of Hospital Infection 37, 145 156.
55. Maki D.G., Ringer M. Alvarado C.J. (1991) Prospective randomized trial of povidone iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338, 339 343.
56. Maki D.G., Stolz S.M., Wheeler S. Mermel L.A. (1997) Prevention of central venous catheter-related bloodstream infection by use of antiseptic impregnated catheter. A randomised controlled trial. Annals of Internal Medicine 127, 257 266.
57. Makris M., Greaves M., Phillips W.S., Kitchen S., Rosendaal F.R. Preston E.F. (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and Haemostasis 77, 477 480.
58. Mayer T. Wong D.G. (2002) The use of polyurethane PICCs an alternative to other materials. Journal of Vascular Access Devices 3, 26 29.
59. Medicines and Healthcare Products Regulatory Agency (MHRA) (2005) Medical Device Alert on All Brands of Needle Free Intra Vascular Connectors. MDA/2005/030, London.
60. Meier P., Fredrickson M., Catney M. Nettleman M. (1998) Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. American Journal of Infection Control 26, 388 392.
61. Mermel L.A., McCormack R.D., Springman S.R. Maki D.G. (1991) The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study using molecular sub-typing. American Journal of Medicine 91 (Suppl. 3B 197S 205S.
62. Miller J., Goetz A., Squier C. Muder R. (1996) Reduction in nosocomial intravenous device-related bacteraemias after institution of an intravenous therapy team. Journal of Intravenous Nursing 19, 103 106.
63. Moller T., Borregaard N., Tvede M. Adamsen L. (2005) Patient education-a strategy for prevention of infections caused by permanent central venous catheters in patients with haematological malignancies: a randomized clinical trial. Journal of Hospital Infection 61, 330 341.
64. Morris P., Grace S., Glackin V., Akers N., McNamarra G., Seale T. Nicol A. (1995) Audit of skin-tunnelled catheters in neutropenic patients. Bone Marrow Transplantation 15 (Suppl. 2 685, S168.
65. Motonaga G.K., Lee K.K. Kirsch J.R. (2004) The efficacy of the arrow staple device for securing central venous catheters to human skin. Anesthesia & Analgesia 99, 1436 1439.
66. Mumtaz H., Williams V., Hauer-Jenson M., Rowe M., Henry-Tillman R.S., Heaton K., Mancino A.T., Muldoon R.L., Kilmberg V.S., Broadwater J.R., Westbrook K.C. Lang N.P. (2000) Central venous catheter placement in patients with disorders of Hemostasis. American Journal of Surgery 180, 503 505.
67. NICE (2002) Guidance on the Use of Ultrasound Locating Devices for Central Venous Catheters. NICE Technology Appraisal 49. National Institute for Clinical Excellence, London.
68. NICE (2003) Infection Control Prevention of Healthcare Associated Infection in Primary and Community Care. DOH, National Institute for Clinical Excellence, London, Clinical Guidelines 2.
69. O'Grady N.P., Alexander M., Dellinger E.P., Gerberdin J.L., Heard S.O., Maki D.G., Masur H., McCormick R.D., Mermel L.A., Pearson M.L., Raad I.I., Randolph A. Weinstein R.A. (2002) Guidelines for the prevention of intravascular catheter-related infections. American Journal of Infection Control 30, 476 489 (review).
70. Passannante A. Macik B.G. (1998) Case report: the heparin flush syndrome: a cause of iatrogenic haemorrhage. American Journal of Medical Science 296, 71 73.
71. Pegues D., Axelrod P., McClarren C., Eisenberg B.L., Hoffman J.P., Ottery F.D., Keidan R.D., Boraas M. Weese J. (1992) Comparison of infections with Hickman and implanted port catheters in adult solid tumor patients. Journal of Surgical Oncology 49, 156 162.
72. Pellowe C.M., Pratt R.J., Harper P., Loveday H.P., Robinson N., Jones S.R., MacRae E.D., Mulhall A., Smith G.W., Bray J., Carroll A., Chieveley Williams S., Colpman D., Cooper L., McInnes E., McQuarrie I., Newey J.A., Peters J., Pratell,i N., Richardson G., Shah P.J., Silk D. Wheatley C. (2003) Guideline Development Group. (2003) Evidence-based guidelines for preventing healthcare-associated infections in primary and community care in England. Journal of Hospital Infection 55 (Suppl. 2 S2 S127.
73. Polderman K. Girbes A. (2002) Central venous catheter use: part 1: mechanical complications. Intensive Care Medicine 28, 1 17.
74. Pratt R.J., Pellowe C., Loveday H.P., Robinson N., Smith G.W., Barrett S., Davey P., Harper P., Loveday C., McDougall C., Mulhall A., Privett S., Smales C., Taylor L., Weller B. Wilcox M. (2001) The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: guidelines for preventing hospital-acquired infections. Department of Health (England). Journal of Hospital Infection 47 (Suppl. S1 S82.
75. Primhak R.H. (1998) Pressures used to flush central venous catheters. Archives of Disease in Childhood Fetal & Neonatal Edition 78, F234.
76. Raad I.I., Hohn D.C., Gilbreath B.J., Suleiman N., Hill L.A., Bruso P.A., Marts K., Mansfield P.F. Bodey G.P. (1994) Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology 15, 231 238.
77. Randolph A., Cook D.J., Gonzales C.A. Brun-Buisson C. (1998) Tunnelling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized controlled trials. Critical Care Medicine 26, 1452 1457.
78. Ray C.E. Jr. Shenoy S.S. (1997) Patients with thrombocytopenia: Outcome of radiological placement of central venous access devices. Radiology 204, 97 99.
79. RCN (2005) Royal College of Nursing IV Therapy Forum. Standards for Infusion Therapy. Royal College of Nursing, London. Avaliable at: http://www.rcn.org.uk/publications/pdf/002179.pdf (accessed on 22 June 2007).
80. Reynolds M.G., Tebbs S.E. Elliott T.S.J. (1997) Do dressings with increased permeability reduce the incidence of central venous catheter related sepsis. Intensive and Critical Care Nursing 13, 26 29.
81. Richet H., Hubert B., Nitemberg G., Andremont A., Buu-Hoi A., Ourbak P., Galicier C., Veron M., Boisivon A. Bouvier A.M. (1991) Prospective multicentre study of vascular-catheter-related complications and risk factors for positive central catheter cultures in intensive care unit patients. Journal of Clinical Microbiology 28, 2520 2525.
82. Rijnders B.J., Van Wijngaerden E., Vandecasteele S.J., Stas M. Peetermans W.E. (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. Journal of Antimicrobial Chemotherapy 55, 90 94.
83. Sharma A., Bodenham A.R. Mallick A. (2004) Ultrasound guided infraclavicular axillary vein cannulation for central venous access. British Journal of Anaesthesia 9, 188 192.
84. Soifer N., Borzak S., Edlin B. Weinstein R. (1998) Prevention of peripheral venous catheter complications with an intravenous therapy team. Archives of Internal Medicine 158, 473 477.
85. Solomon S. Stoddard G. (2001) The infusion nurse and patient complication rates of peripheral-short catheters. Journal of Intravenous Nursing 24, 113 123.
86. Trerotola S.O. (2000) Hemodialysis catheter placement and management. Radiology 215, 651 656.
87. Treston-Aurand J., Olmsted R.N., Allen-Bridson K. Craig C.P. (1997) Impact of dressing materials on central venous catheter infection rates. Journal of Intravenous Nursing 20, 201 206.
88. Trottier S.J., Veremakis S.C., O'Brien J. Auer A.I. (1995) Femoral deep vein thrombosis associated with central venous catheterization: Results from a prospective randomized trial. Critical Care Medicine 23, 52 59.
89. Vesely T.M. (2003) Central venous catheter tip position: A continuing controversy. Journal of Vascular and Interventional Radiology 14, 527 534.
90. Watson H.G., Baglin T., Laidlaw S.L., Makris M. Preston F.E. (2001) A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. British Journal of Haematology 115, 145 149.
91. Whitman E.D. (1996) Complications associated with the use of central venous access devices. Current Problems in Surgery 23, 309 388.
92. Yamamoto A.J., Solomon J.A., Soulen M.C., Tang J., Parkinson K., Lin R. Schears G.J. (2002) Sutureless securement devices reduces the complications of peripherally inserted central venous catheters. Journal of Vascular and Interventional Radiology 13, 77 81.
93. Yasaka M., Sakata T., Minematsu K. Naritomi H. (2002) Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thrombosis Research 108, 25 30.
94. Yebenes J.C., Vidaur L., Serra-Prat M., Sirvent J.M., Batlle J., Motje M., Bonet A. Palomar M. (2004) Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. American Journal of Infection Control 32, 291 295.
95. Young A.M., Begum G., Billingham L.J., Hughes D.J., Kerr D., Rea A., Stanley A., Sweeney K. Wheatley J.W. (2005) WARP Collaborative Group, UK, 2005, WARP - a multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). ASCO Meeting Abstracts June 23 (16S LBA8004.